Beta Bionics ( BBNX ) Q2 Revenue Soars 54%
Beta Bionics ( NASDAQ:BBNX ) , a medical technology firm focused on diabetes management solutions, reported earnings for Q2 2025 on July 29, 2025. The headline news was a strong revenue increase to $23.2 million ( GAAP ) , notably above the $19.7 million consensus estimate ( GAAP ) .
Beta Bionics BBNX Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, July 29, 2025 at 12:00 a.m. ETChief Executive Officer - Sean SaintContinue reading ...
Merit Medical Names Martha Aronson as New President and Chief Executive Officer - Merit Medical Systems ( NASDAQ:MMSI )
Fred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 ( GLOBE NEWSWIRE ) -- Merit Medical Systems, Inc.
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns - Beta Bionics ( NASDAQ:BBNX ) , Cognition Therapeutics ( NASDAQ:CGTX )
Sonnet BioTherapeutics Holdings Inc. SONN stock experienced a drop of 5.54% on Thursday, followed by a remarkable recovery of 14.29% in after-hours trading. What Happened: Sonnet BioTherapeutics' stock fell by 5% during regular trading hours on Thursday.
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
IRVINE, Calif., July 02, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc. ( Nasdaq: BBNX ) , a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 financial results after the financial markets close on ...
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - Beta Bionics ( NASDAQ:BBNX )
IRVINE, Calif., July 02, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc. BBNX, a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 financial results after the financial markets close on Tuesday, July 29, ...
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
CHICAGO, June 24, 2025 ( GLOBE NEWSWIRE ) -- Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the closing of its initial seed financing led by Zubi Capital, in ...
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
Beta Bionics collaborates with Abbott to integrate its iLet system with a dual sensor, aiming to simplify and enhance diabetes care.
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor
IRVINE, Calif., June 19, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery ( AID ) system with Abbott's future dual ...
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Beta Bionics ( NASDAQ:BBNX ) , Insulet ( NASDAQ:PODD ) , DexCom ( NASDAQ:DXCM )
Goldman sets $380 target for Insulet, citing Omnipod's unique design and share capture potential. Dexcom gets $104 target, expected to gain share in non-insulin diabetes segments through 2025. Rebound or breakdown? See how Matt Maley is trading June's market volatility, live this Wednesday, June ...
Beta Bionics to Present at the Bank of America Securities Health Care Conference - Beta Bionics ( NASDAQ:BBNX )
IRVINE, Calif., May 01, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc. BBNX, a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 13, 2025 ...
Beta Bionics to Host Investor Event on June 22, 2025
IRVINE, Calif., April 09, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc. ( Nasdaq: BBNX ) ( the "Company" ) , a pioneering leader in the development of advanced diabetes management solutions, today announced that it will host an investor event on Sunday, June 22, 2025, in conjunction with the ...
Beta Bionics to Host Investor Event on June 22, 2025 - Beta Bionics ( NASDAQ:BBNX )
IRVINE, Calif., April 09, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc.
Beta Bionics Announces Board Appointment of Gerard Michel - Beta Bionics ( NASDAQ:BBNX ) , Delcath Systems ( NASDAQ:DCTH )
IRVINE, Calif., March 27, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc. BBNX, a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its board of directors, effective March 26, 2025.
Beta Bionics Announces Board Appointment of Gerard Michel
IRVINE, Calif., March 27, 2025 ( GLOBE NEWSWIRE ) -- Beta Bionics, Inc. ( Nasdaq: BBNX ) , a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its board of directors, effective March 26, ...
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Beta Bionics ( NASDAQ:BBNX ) , Compass Therapeutics ( NASDAQ:CMPX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Barclays analyst Benjamin Budish initiated coverage on Blue Owl Capital Inc.
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Beta Bionics ( NASDAQ:BBNX ) , Candel Therapeutics ( NASDAQ:CADL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Loop Capital analyst Mark Schappel initiated coverage on Palantir Technologies Inc.
